Allega MF, Deshmukh R, Hillinger T, Akhmetshina A, Oudin A, Bielik R, Soloviev D, Villar VH, Ackermann T, Bourmeau G, Chahal SK, Stevenson KH, Nixon C, Shaw R, Morrison GM, Chalmers AJ, Pollard SM, Lund-Johansen M, Bjerkvig R, Seano G, Niclou SP, Vik-Mo EO, Lewis DY, Sumpton D, Tardito S (2026)
Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma
Sci Adv, 12 (4), eadx6539
DOI 10.1126/sciadv.adx6539, PubMed 41576167

Karschnia P, Young JS, Wijnenga MMJ, Sciortino T, Teske N, Corell A, Wagner A, Youssef G, Park YW, Häni L, Jünger ST, Dono A, Ehret F, Mireles EEM, Neidert N, Bruno F, Tuchek CA, van der Vaart T, Rossi M, Nibali MC, Gay L, Gramelt A, Tandon N, Ahn SS, Chang JH et al. (2025)
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group
Lancet Oncol, 26 (12), 1638-1650
DOI 10.1016/S1470-2045(25)00534-0, PubMed 41308678

Emblem KE, Ringstad G, Svensson SF, Vatnehol SAS, Storås TH, Vik-Mo EO, Heggebø LC, Brandal P, Eide PK (2025)
Intrathecal contrast-enhanced MRI reveals an alternative route for drug delivery and brain tumor visualization
Cancer Lett, 638, 218152
DOI 10.1016/j.canlet.2025.218152, PubMed 41276108